Leukemia
Researchers' findings advance leukemia research
Published in Blood Weekly, March 30th, 2006
Study 1: Valproic acid (VPA) was deemed clinically useful in low-risk myelodysplastic syndrome (MDS).
According to a study from Germany, "VPA inhibits historic deacetylase activity and induces differentiation of acute myeloid leukemia (AML) blasts in vitro. We observed clinical responses to VIA in patients with MDS and AML."
"Here, we report follow-up data on 75 patients. Of these, 66 were started on VPA monotherapy, with later addition of all-trans retinoic acid (ATRA) in patients who did not respond or relapsed. Nine patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-03-30)
More Articles from Blood Weekly
- Blood Banking
Premier's plasma and recombinant program helps hospitals acquire products in short supply - Blood Safety
HIV prevalence in donated blood reduced after enhanced education and selection process - Blood Safety
Repeat blood donors have lower transfusion-transmissible infections than new donors - Blood Safety
Transfusion-associated Trypanosoma cruzi transmission occurring in Mexican blood banks - Blood Safety
West Nile virus-associated self-reported symptoms do not predict infection in blood donors - Angiology
High-dose folic acid does not protect vascular endothelium from IR injury in humans - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
